Clinical Trial Update: Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting completion of an oral drug study in women with refractory metastatic breast cancer after prior Herceptin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Metastatic Breast Cancer, Neoplasms, Breast | Phase 2 | Status: COMPLETED